Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions
JACC: Cardiovascular Interventions · 2024-04 · 17 (7) · 859-870
DOI: 10.1016/j.jcin.2024.02.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Cardiovascular Interventions, 2024-04. Verfasst von Marianna Adamo und 51 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, It…. Hauptthemen laut MEDLINE: Heart Failure, Heart Valve Prosthesis Implantation, Tricuspid Valve Insufficiency. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
BACKGROUND: Data on the prognostic role of the TRI-SCORE in patients undergoing transcatheter tricuspid valve intervention (TTVI) are limited. OBJECTIVES: The aim of this study was to evaluate the performance of the TRI-SCORE in predicting outcomes of patients undergoing TTVI. METHODS: TriValve (Transcatheter Tricuspid Valve Therapies) is a large multicenter multinational registry including patients undergoing TTVI. The TRI-SCORE is a risk model recently proposed to predict in-hospital mortality after tricuspid valve surgery. The TriValve population was stratified based on the TRI-SCORE tertiles. The outcomes of interest were all-cause death and all-cause death or heart failure hospitalization. Procedural complications and changes in NYHA functional class were also reported. RESULTS: Among the 634 patients included, 223 patients (35.2%) had a TRI-SCORE between 0 and 5, 221 (34.8%) had 6 or 7, and 190 (30%) had ≥8 points. Postprocedural blood transfusion, acute kidney injury, new atrial fibrillation, and in-hospital mortality were more frequent in the highest TRI-SCORE tertile. Postprocedure length of stay increased with a TRI-SCORE increase. A TRI-SCORE ≥8 was associated with an increased risk of 30-day all-cause mortality and all-cause mortality and the composite endpoint assessed at a median follow-up of 186 days (OR: 3.00; 95% CI: 1.38-6.55; HR: 2.17; 95% CI: 1.78-4.13; HR: 2.08, 95% CI: 1.57-2.74, respectively) even after adjustment for procedural success and EuroSCORE II or Society of Thoracic Surgeons Predicted Risk of Mortality. The NYHA functional class improved across all TRI-SCORE values. CONCLUSIONS: In the TriValve registry, the TRI-SCORE has a suboptimal performance in predicting clinical outcomes. However, a TRISCORE ≥8 is associated with an increased risk of clinical events and a lack of prognostic benefit after successful TTVI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy. Electronic address: mariannaadamo@hotmail.com.
- Department of Biomedicine and Prevention, Cardiology Unit, Policlinico Tor Vergata, University of Rome, Rome, Italy.
- Institute of Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
- Department of Cardiology, Asklepios Clinic Sankt Georg, Hamburg, Germany.
- Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
- Department of Medicine and Surgery, University Milano Bicocca, Milan, Italy; Department of Cardiology, Auxologico IRCCS, Milan, Italy.
Zitieren
APA
Adamo, M., Russo, G., Pagnesi, M., Pancaldi, E., Alessandrini, H., Andreas, M., Badano, L. P., Braun, D., Connelly, K. A., Denti, P., Estevez-Loureiro, R., Fam, N., Gavazzoni, M., Hahn, R. T., Harr, C., Hausleiter, J., Himbert, D., Kalbacher, D., Ho, E., …, & Taramasso, M. (2024). Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions. JACC: Cardiovascular Interventions, 17(7), 859-870. https://doi.org/10.1016/j.jcin.2024.02.013
Vancouver
Adamo M, Russo G, Pagnesi M, Pancaldi E, Alessandrini H, Andreas M, et al. Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions. JACC: Cardiovascular Interventions. 2024;17(7):859-870. doi:10.1016/j.jcin.2024.02.013
BibTeX
@article{Adamo2024,
author = {Adamo, Marianna and Russo, Giulio and Pagnesi, Matteo and Pancaldi, Edoardo and Alessandrini, Hannes and Andreas, Martin and Badano, Luigi P and Braun, Daniel and Connelly, Kim A and Denti, Paolo and Estevez-Loureiro, Rodrigo and Fam, Neil and Gavazzoni, Mara and Hahn, Rebecca T and Harr, Claudia and Hausleiter, Joerg and Himbert, Dominique and Kalbacher, Daniel and Ho, Edwin and Latib, Azeem and Lubos, Edith and Ludwig, Sebastian and Lupi, Laura and Lurz, Philipp and Monivas, Vanessa and Nickenig, Georg and Pedicino, Daniela and Pedrazzini, Giovanni and Pozzoli, Alberto and Marafon, Denise Pires and Pastorino, Roberta and Praz, Fabien and Rodes-Cabau, Joseph and Besler, Christian and Schöber, Anne Rebecca and Schofer, Joachim and Scotti, Andrea and Piayda, Kerstin and Sievert, Horst and Tang, Gilbert H L and Sticchi, Alessandro and Messika-Zeitoun, David and Thiele, Holger and Schlotter, Florian and von Bardeleben, Ralph Stephan and Webb, John and Dreyfus, Julien and Windecker, Stephan and Leon, Martin and Maisano, Francesco and Metra, Marco and Taramasso, Maurizio},
title = {Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions},
journal = {JACC: Cardiovascular Interventions},
year = {2024},
volume = {17},
number = {7},
pages = {859--870},
doi = {10.1016/j.jcin.2024.02.013}
}
EUVIMED